JENNISON ASSOCIATES LLC 13D and 13G filings for Marinus Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-12 09:55 am Sale | 2024-09-30 | 13G | Marinus Pharmaceuticals, Inc. MRNS | JENNISON ASSOCIATES LLC | 0 0.000% | -2,959,161 (Position Closed) | Filing |
| 2024-02-08 1:56 pm Purchase | 2023-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS | JENNISON ASSOCIATES LLC | 2,959,161 5.400% | 2,959,161 (New Position) | Filing |